Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
antongiulio.faggiano@uniroma1.it
Antongiulio Faggiano
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
antongiulio.faggiano@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Efficacy and safety of everolimus in extrapancreatic neuroendocrine tumor: a comprehensive review of literature
THE ONCOLOGIST
2016
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study
ENDOCRINE
2016
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma
ANNALS OF NUCLEAR MEDICINE
2016
Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life
ONCOTARGET
2016
Benign thyroid nodules with RAS mutation grow faster
CLINICAL ENDOCRINOLOGY
2016
Low glycaemic diet and metformin therapy. a new approach in male subjects with acne resistant to common treatments
CLINICAL AND EXPERIMENTAL DERMATOLOGY
2016
Rare diseases in clinical endocrinology: a taxonomic classification system
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2015
Italian Society of Endocrinology Consensus Statement: Definition, evaluation and management of patients with mild primary hyperparathyroidism
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2015
Pituitary function and morphology in Fabry disease
ENDOCRINE
2015
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib
ENDOCRINE
2015
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication
ENDOCRINE
2015
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge
ENDOCRINE
2015
The evolving field of kinase inhibitors in thyroid cancer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2015
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2015
Letter. the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2015
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2015
Epidemiology of Neuroendocrine Tumors
Neuroendocrine Tumors. A Multidisciplinary Approach
2015
Erratum to. GLP-1. benefits beyond pancreas
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2015
« first
< previous
1
2
3
4
5
6
7
8
9
10
11
ERC
LS2_1
LS2_14
LS4_4
LS4_9
LS4_12
LS7_4
LS7_8
LS7_10
LS7_14
KET
Life-science technologies & biotechnologies
Interessi di ricerca
Keywords
neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma